PKG

Advantest to Exhibit Latest Test Solutions at SEMICON Southeast Asia, May 28-30

Retrieved on: 
星期一, 五月 20, 2024
Gold, Gallium nitride, International trade, Automation, CREA, Advantest, Data-rate units, Safety, PKG, Silicon carbide, AI, DRAM, Future Together, Convention center, WLBI, Innovation, HPC, Printed circuit board

TOKYO, May 20, 2024 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at SEMICON Southeast Asia 2024 on May 28-30 at the Malaysia International Trade and Exhibition Centre (MITEC) in Kuala Lumpur, Malaysia.

Key Points: 
  • TOKYO, May 20, 2024 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at SEMICON Southeast Asia 2024 on May 28-30 at the Malaysia International Trade and Exhibition Centre (MITEC) in Kuala Lumpur, Malaysia.
  • Under the theme of “Facing the Future Together,” Advantest will honor this important milestone with valued customers and industry partners at SEMICON Southeast Asia 2024.
  • In Hall 3 booth #1008, Advantest will exhibit a broad range of test solutions that enable critical applications like high-performance computing (HPC), AI, automotive, and 5G/IoT.
  • HA1200 , offering die test capability with active thermal control to enable at-speed 100% test coverage before the dies are assembled into 2.5D/3D packages.

Advantest to Exhibit Latest Test Solutions at SEMICON China, March 20-22 in Shanghai

Retrieved on: 
星期二, 三月 12, 2024
IEEE 802.11be, PKG, Socs, ICS, RDK, OTA, Silicon carbide, SOC, LCD, Conference, WiGig, Gallium nitride, Internet of things, WLBI, DRAM, HPC, Integrated circuit, AI, Wi-Fi, IP, CREA, CP, Future, Advantest, CIS, Printed circuit board

TOKYO, March 12, 2024 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at SEMICON China 2024 on March 20-22 at the Shanghai New International Exhibit Center (SNIEC).

Key Points: 
  • TOKYO, March 12, 2024 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at SEMICON China 2024 on March 20-22 at the Shanghai New International Exhibit Center (SNIEC).
  • In a unique application-based exhibit, Advantest will highlight how its test technology enables leading-edge innovations in high-performance computing (HPC), AI, automotive, IoT and 5G.
  • Advantest aims to develop test technology that supports a safe, secure and sustainable society, showcasing its sustainability initiatives at this year's event.
  • Wide-ranging DRAM turn-key test solutions, including wafer-level burn-in, DRAM wafer test, core final test, and at-speed interface test.

Advantest to Showcase Latest Test Solutions at SEMICON Japan, Dec. 13-15 in Tokyo

Retrieved on: 
星期二, 十二月 12, 2023
ICS, DFT, STS, Marketing, SLT, Ecosystem, LCD, PCI Express, East Hall, Advantest, CIS, Wi-Fi, SSD, SVC, XR, AI, Internet of things, PKG, IEEE 802.11be, HPC, Data-rate units, WiGig, Silicon carbide, Socs, IP, SCAN, Gallium nitride, WLBI, NVM Express, MBIST, SOC, Safety, RDK, LBIST, OTA, ACS, CREA, Solid-state drive, Printed circuit board

TOKYO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at SEMICON Japan 2023 on December 13-15 at the Tokyo Big Sight.

Key Points: 
  • TOKYO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at SEMICON Japan 2023 on December 13-15 at the Tokyo Big Sight.
  • In booth #1648, Hall 1, Advantest will showcase its broad range of test technologies enabling the evolution of increasingly complex semiconductors, which are essential to our daily lives.
  • NEW: HA1200 , offering die test capability with active thermal control to enable at-speed 100% test coverage before the dies are assembled into 2.5D/3D packages.
  • NEW: T5230 memory test system adopts a combined array architecture to reduce test cost for NAND/NVM wafer test, including wafer-level burn-in (WLBI).

Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO

Retrieved on: 
星期三, 五月 3, 2023
Disease, DSM-IV codes, Huntington's disease, Research, MD, Patient, Algorithm, Parkinson's disease, United Kingdom, Growth, Dyskinesia, PKG, Movement disorder, NHS, NICE, Caregiver, Kinetics, National Institute for Health and Care Excellence, Management, Pharmaceutical industry, Chorea, Hypokinesia, UPDRS

Zach joins Global Kinetics with over 25 years of healthcare software and big data experience and will lead Global Kinetics' continued growth and global expansion.

Key Points: 
  • Zach joins Global Kinetics with over 25 years of healthcare software and big data experience and will lead Global Kinetics' continued growth and global expansion.
  • Zach recently served as the Chief Commercial Officer of Glooko, where he led the rapid growth of the business with life science partners and healthcare providers.
  • "With the largest body of published clinical evidence and over 35,000 patients treated, Global Kinetics has the deepest clinical data set in the neurology field," said Zach Henderson, newly appointed CEO of Global Kinetics.
  • Mr. Henderson's appointment as CEO follows several exciting announcements for Global Kinetics.

Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO

Retrieved on: 
星期三, 五月 3, 2023
Disease, DSM-IV codes, Huntington's disease, Research, MD, Patient, Algorithm, Parkinson's disease, United Kingdom, Growth, Dyskinesia, PKG, Movement disorder, NHS, NICE, Caregiver, Kinetics, National Institute for Health and Care Excellence, Management, Pharmaceutical industry, Chorea, Hypokinesia, UPDRS

Zach joins Global Kinetics with over 25 years of healthcare software and big data experience and will lead Global Kinetics' continued growth and global expansion.

Key Points: 
  • Zach joins Global Kinetics with over 25 years of healthcare software and big data experience and will lead Global Kinetics' continued growth and global expansion.
  • Zach recently served as the Chief Commercial Officer of Glooko, where he led the rapid growth of the business with life science partners and healthcare providers.
  • "With the largest body of published clinical evidence and over 35,000 patients treated, Global Kinetics has the deepest clinical data set in the neurology field," said Zach Henderson, newly appointed CEO of Global Kinetics.
  • Mr. Henderson's appointment as CEO follows several exciting announcements for Global Kinetics.

Trip.com Group invites travel industry to journey into the future together at global partner summit

Retrieved on: 
星期五, 十二月 2, 2022
Sale, Skyscanner, PKG, City, Tourism, Future Together, Travel, Communication, Growth, HKEX, RMB, Marketing, Ecosystem, GMV, Sun Bo, Government, CMO, Oil, Airline, Online shopping, Casino, Trip.com Group

MACAO, Dec. 2, 2022 /PRNewswire/ -- Leading travel service provider Trip.com Group held its 2022 Global Partner Summit in Macao, with tourism boards, international airlines, hotel groups and industry representatives from across the travel industry in attendance.

Key Points: 
  • MACAO, Dec. 2, 2022 /PRNewswire/ -- Leading travel service provider Trip.com Group held its 2022 Global Partner Summit in Macao, with tourism boards, international airlines, hotel groups and industry representatives from across the travel industry in attendance.
  • It's our mission to help build communication and innovation, using our travel platform to create new value for the industry."
  • Trip.com Group is continuously safeguarding efforts toward global travel recovery by following its 'Local Focus, Global Vision' blueprint.
  • Trip.com Group is a leading global travel service provider comprising of Trip.com, Ctrip, Skyscanner, Qunar and TrainPal.

CES 2022: Seoul Semiconductor to Exhibit All Light Sources Including MICRO DISPLAY Required for Autonomous Driving of Future Vehicle

Retrieved on: 
星期三, 十二月 22, 2021
Hardware, Semiconductor, Automotive Manufacturing, Manufacturing, Consumer Electronics, Technology, Infectious Diseases, General Automotive, Other Technology, Other Manufacturing, Science, Automotive, Other Science, Health, Research, IR, LCD, Technology, Virus, UV, VIP, Seoul Semiconductor, LED, COB, VCSEL, Sterilization, CSP, OLED, Traffic, Bacteria, CES, PKG, Blue–green distinction in language, Pedestrian, Light, Solution, Car, AC, Main sequence, Safety, Atmosphere, KOSDAQ, Multimedia, EPI, Mobile phone, Television set

At CES 2022, Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global optical semiconductor company, will demonstrate a Micro Display for vehicle (WICOP mc) to communicate with pedestrians or oncoming drivers during autonomous driving, and a solution to sterilize the in-vehicle air.

Key Points: 
  • At CES 2022, Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global optical semiconductor company, will demonstrate a Micro Display for vehicle (WICOP mc) to communicate with pedestrians or oncoming drivers during autonomous driving, and a solution to sterilize the in-vehicle air.
  • In addition, the company will demonstrate WICOP ADB (Adaptive Driving Beam: Intelligent Headlamp), which improves the visibility of oncoming vehicles or pedestrians while driving.
  • Seoul Semiconductor will begin mass production of its sterilization technology, Violeds, in January at one of the top five global companies.
  • Seoul Semiconductor is the worlds second-largest global LED manufacturer, a ranking excluding the captive market, and has more than 10,000 patents.

Cerebain Biotech Closes Share Exchange Agreement With PKG, Inc.

Retrieved on: 
星期一, 九月 20, 2021
Medical Devices, Health, News, OTC, Risk, Engineering, Ownership, Omentum, PKG, CBBT, Twitter, Company, OTC Markets Group, Forward-looking statement, Dementia, Government, ID, Medical device

Cerebain Biotech Corp. (OTC: CBBT), (the Company or Cerebain) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership of PKG, Inc.

Key Points: 
  • Cerebain Biotech Corp. (OTC: CBBT), (the Company or Cerebain) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership of PKG, Inc.
    Cerebain Biotech Corp. (OTC: CBBT) is a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device and a synthetic drug solution.
  • The device leverages the clinically observable, positive impact that Omentum stimulation has on cognitive function as related to dementias, and in particular, Alzheimers disease.
  • Visit us at www.cerebain.com or connect with us on Twitter and Facebook to learn more.
  • PKG, Inc. was established in 1989 and is a privately held corporation based in Meridian, ID.

Global Kinetics Enters Remote Monitoring Business and Appoints New U.S. Commercial Leadership

Retrieved on: 
星期四, 八月 19, 2021
PD, Standard of care, PKG, DBS, Quality of life, Program, GK, Lists of diseases, Neurology, Merck KGaA v. Integra Lifesciences I, Ltd., Movement, GLOBE, CMS, Kinetics, RPM, GKC, Economics, Person, Marketing, Time, Clinic, Asia, Review, Clinical trial, Personal, U.S. Navy Diving Manual, Patient, FDA, COVID-19, Level 1, Medical device, Pharmaceutical industry

Global Kinetics provides device fulfillment directly to the patients home and delivers comprehensive annotated reports via a clinic-facing portal.

Key Points: 
  • Global Kinetics provides device fulfillment directly to the patients home and delivers comprehensive annotated reports via a clinic-facing portal.
  • The PKG is ideally suited to support remote and telehealth visits which have increased during the global COVID-19 pandemic.
  • The PKG using remote monitoring was initially tested with several Movement Disorder Clinics in the U.S. prior to being released for commercial use.
  • To lead the U.S. commercial business, Global Kinetics is pleased to announce that DavidBuche is joining the company as the Vice President Sales and Marketing, General Manager US RPM Business.

Packaging Corporation of America Schedules Conference Call to Discuss Second Quarter 2021 Operating Results

Retrieved on: 
星期五, 六月 25, 2021
Packaging, Other Natural Resources, Forest Products, Manufacturing, Natural Resources, Other Manufacturing, New York Stock Exchange, Conference call, PKG, Service industries

Packaging Corporation of America (NYSE: PKG) will hold a conference call on Tuesday, July 27, 2021 at 9:00 a.m. Eastern Time to discuss second quarter 2021 results.

Key Points: 
  • Packaging Corporation of America (NYSE: PKG) will hold a conference call on Tuesday, July 27, 2021 at 9:00 a.m. Eastern Time to discuss second quarter 2021 results.
  • Second quarter earnings results will be released after the market closes on Monday, July 26, 2021.
  • To access the conference call, please dial (855) 730-0288 (U.S. and Canada) or (832) 412-2295 (International) by 8:45 a.m. (Eastern Time).
  • The conference call leader will be Mark Kowlzan, and the conference ID is 1088155.